Could Skin Autofluorescence Be a Useful Biomarker in Systemic Lupus Erythematosus? A Systematic Review
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26146934 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Teodor Salmen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania. Hauptthemen laut MEDLINE: Biomarkers, Lupus Erythematosus, Systemic, Optical Imaging, Skin. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Systemic lupus erythematosus (SLE) is a multifaceted autoimmune disease with a heterogeneous organ involvement, for which reliable biomarkers are still being studied. The implication of advanced glycation end products (AGEs), resulting from oxidative stress, and their interaction with the receptor for AGEs (RAGE) has been studied in pathologies with chronic proinflammatory status, offering potential relevance in SLE. This systematic review aimed to evaluate the utility of skin autofluorescence (SAF)—a non-invasive proxy for AGE accumulation—as a biomarker for disease severity, activity, and impact in SLE patients. Following PRISMA guidelines, six studies assessing SAF and/or circulating AGEs and soluble RAGE (sRAGE) in SLE were analyzed. Findings consistently showed higher AGE levels in SLE patients compared to healthy controls, with several correlations between SAF/AGEs and disease features such as SLEDAI scores, organ involvement, inflammatory markers, and damage indices. Decreased sRAGE levels were also observed, possibly due to consumption by AGEs. Some studies further reported predictive associations between specific AGEs or their ratios with sRAGE and particular clinical phenotypes. Although heterogeneity among studies limits definitive conclusions, the AGEs–sRAGE axis—and especially SAF—emerges as a promising candidate for future biomarker development in SLE. Further large-scale longitudinal studies are needed to confirm its clinical utility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Doctoral School, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
- Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
- Department of Rheumatology and Internal Medicine, Sfânta Maria Clinical Hospital, 011172 Bucharest, Romania.
- Department of Surgery II, Sfânta Maria Clinical Hospital, 011172 Bucharest, Romania.
- Department of Rheumatology and Internal Medicine, Colentina Clinical Hospital, 072202 Bucharest, Romania.
- Department of Diabetes, Nutrition and Metabolic Diseases, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
ORCID-Profile: Teodor Salmen, Bianca-Margareta Salmen, Gabriela-Claudia Potcovaru, Daniela Opris-Belinski, Anca Pantea Stoian
Zitieren
APA
Salmen, T., Cobilinschi, C., Mihăilescu, A., Salmen, B. M., Potcovaru, G. C., Opris-Belinski, D., Copcă, N., Caraiola, S., Negoi, F., Pantea Stoian, A., & Săulescu, I. (2025). Could Skin Autofluorescence Be a Useful Biomarker in Systemic Lupus Erythematosus? A Systematic Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26146934
Vancouver
Salmen T, Cobilinschi C, Mihăilescu A, Salmen BM, Potcovaru GC, Opris-Belinski D, et al. Could Skin Autofluorescence Be a Useful Biomarker in Systemic Lupus Erythematosus? A Systematic Review. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26146934
BibTeX
@article{Salmen2025,
author = {Salmen, Teodor and Cobilinschi, Claudia and Mihăilescu, Andrei and Salmen, Bianca-Margareta and Potcovaru, Gabriela-Claudia and Opris-Belinski, Daniela and Copcă, Narcis and Caraiola, Simona and Negoi, Florentina and Pantea Stoian, Anca and Săulescu, Ioana},
title = {Could Skin Autofluorescence Be a Useful Biomarker in Systemic Lupus Erythematosus? A Systematic Review},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26146934}
}
EUVIMED